Amundi’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$526M Buy
6,070,236
+1,616,739
+36% +$155M 0.14% 132
2025
Q4
$428M Buy
4,453,497
+441,516
+11% +$42.9M 0.12% 175
2025
Q3
$395M Sell
4,011,981
-1,065,123
-21% -$97.9M 0.13% 139
2025
Q2
$448M Buy
5,077,104
+803,584
+19% +$68.1M 0.15% 126
2025
Q1
$376M Sell
4,273,520
-610,064
-12% -$54.6M 0.14% 156
2024
Q4
$404M Buy
4,883,584
+31,794
+0.7% +$2.75M 0.14% 147
2024
Q3
$428M Buy
4,851,790
+624,135
+15% +$52.5M 0.16% 135
2024
Q2
$326M Buy
4,227,655
+123,436
+3% +$10.1M 0.13% 161
2024
Q1
$325M Sell
4,104,219
-1,072,627
-21% -$91.5M 0.14% 157
2023
Q4
$449M Buy
5,176,846
+677,897
+15% +$51.7M 0.2% 121
2023
Q3
$324M Sell
4,498,949
-1,308,885
-23% -$110M 0.16% 145
2023
Q2
$506M Sell
5,807,834
-1,827,019
-24% -$157M 0.26% 95
2023
Q1
$613M Sell
7,634,853
-1,327,024
-15% -$108M 0.33% 66
2022
Q4
$720M Sell
8,961,877
-1,092,561
-11% -$88.6M 0.39% 54
2022
Q3
$855M Buy
10,054,438
+1,159,968
+13% +$104M 0.51% 33
2022
Q2
$778M Buy
8,894,470
+1,689,473
+23% +$171M 0.62% 26
2022
Q1
$809M Buy
7,204,997
+913,908
+15% +$96.6M 0.55% 33
2021
Q4
$684M Buy
6,291,089
+44,810
+0.7% +$5.19M 0.43% 48
2021
Q3
$783M Sell
6,246,279
-1,174,422
-16% -$152M 0.55% 31
2021
Q2
$921M Buy
+7,420,701
New +$932M 0.64% 25

Other funds holding MDT

Amundi's MDT Position: Q1 2026 in Review

Amundi increased its Medtronic (MDT) stake by 36% in Q1 2026, buying an estimated $155M and bringing the position to 6,070,236 shares worth $526M. The position accounts for 0.14% of the portfolio, ranked #132.

Amundi first reported a position in MDT in Q2 2021 and has held it in 20 quarters since. The position peaked at $921M in Q2 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Amundi held 6,070,236 shares of Medtronic worth $526M as of Q1 2026.
  • Amundi bought 1,616,739 Medtronic shares in Q1 2026, an estimated $155M.
  • Medtronic made up 0.14% of Amundi's portfolio in Q1 2026, its #132 holding.
  • Amundi first reported a position in Medtronic in Q2 2021 and has held it in 20 quarters since.
  • Amundi's Medtronic position peaked at $921M in Q2 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.